Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The rosiglitazone story--lessons from an FDA Advisory Committee meeting.

× No keyword cloud information.

64 in total

Review 1. Impact of FDA guidance for developing diabetes drugs on trial design: from policy to practice.

Authors: M Angelyn Bethel; Harald Sourij
Journal: Curr Cardiol Rep Date: 2012-02 Impact factor: 2.931

2. Rosiglitazone: a European regulatory perspective.

Authors: E Blind; K Dunder; P A de Graeff; E Abadie
Journal: Diabetologia Date: 2010-12-14 Impact factor: 10.122

3. Medicine. Moving toward transparency of clinical trials.

Authors: Deborah A Zarin; Tony Tse
Journal: Science Date: 2008-03-07 Impact factor: 47.728

Review 4. Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA.

Authors: Dorrin Zarrin Khat; Mansoor Husain
Journal: Curr Diab Rep Date: 2018-06-09 Impact factor: 4.810

5. Does the method of obtaining glycemic control influence cardiovascular outcomes?

Authors: Anthony L McCall
Journal: Curr Diab Rep Date: 2008-10 Impact factor: 4.810

Review 6. Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment.

Authors: Steven D Lidofsky
Journal: Curr Diab Rep Date: 2008-02 Impact factor: 4.810

7. Diuretics prevent thiazolidinedione-induced cardiac hypertrophy without compromising insulin-sensitizing effects in mice.

Authors: Cherng-Shyang Chang; Pei-Jane Tsai; Junne-Ming Sung; Ju-Yi Chen; Li-Chun Ho; Kumar Pandya; Nobuyo Maeda; Yau-Sheng Tsai
Journal: Am J Pathol Date: 2013-11-26 Impact factor: 4.307

8. Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis.

Authors: Zeina A Habib; Leonidas Tzogias; Suzanne L Havstad; Karen Wells; George Divine; David E Lanfear; Jeffrey Tang; Richard Krajenta; Manel Pladevall; L Keoki Williams
Journal: Pharmacoepidemiol Drug Saf Date: 2009-06 Impact factor: 2.890

9. The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance.

Authors: Amit Kumar; Michael E Matheny; Kalon K L Ho; Robert W Yeh; Thomas C Piemonte; Howard Waldman; Pinak B Shah; Richard Cope; Sharon-Lise T Normand; Sharon Donnelly; Susan Robbins; Frederic S Resnic
Journal: Circ Cardiovasc Qual Outcomes Date: 2014-12-09

Review 10. Cardiovascular effects of noncardiovascular drugs.

Authors: Satish R Raj; C Michael Stein; Pablo J Saavedra; Dan M Roden
Journal: Circulation Date: 2009-09-22 Impact factor: 29.690